Overview

Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if evolocumab added to regular statin therapy improves vein graft patency after coronary artery bypass graft (CABG) surgery.
Phase:
Phase 4
Details
Lead Sponsor:
St. Michael's Hospital, Toronto
Unity Health Toronto
Collaborator:
Applied Health Research Centre
Treatments:
Antibodies, Monoclonal
Evolocumab